Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06567886 · ClinicalTrials.gov registry record · NA

Fibromyalgia Sleep A to ZZZ Study

A NA study of Fibromyalgia, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
390
Enrollment target
1
Study location

NCT06567886 is a NA study of Fibromyalgia that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 390 participants, above the 174-participant average among 76 other Fibromyalgia trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06567886, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
390 participants
Enrollment target
1
Study location

Study Summary

This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.

Conditions Studied

Fibromyalgia

Interventions

  • DEVICE Light Therapy
  • BEHAVIORAL Sleep Stabilization

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 390 participants
Start Date 2024-09-27
Est. Completion 2029-03
Phase NA

Sponsor

University of Michigan

1,327 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06567886

The ClinicalTrials.gov registry entry for NCT06567886 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 174-participant average among 76 other Fibromyalgia trials with a reported enrollment target (124% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Light Therapy is the first listed.

NCT06567886 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06567886 about?

NCT06567886 is a clinical study titled "Fibromyalgia Sleep A to ZZZ Study". This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.

What is the current status of trial NCT06567886?

This trial is currently recruiting. It is a NA study. The enrollment target is 390 participants. The study started on 2024-09-27. Estimated completion is 2029-03.

What conditions does trial NCT06567886 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT06567886?

The interventions under investigation include: Light Therapy (DEVICE), Sleep Stabilization (BEHAVIORAL).

Who is sponsoring clinical trial NCT06567886?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06567886 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fibromyalgia

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.